Detalles de la búsqueda
1.
BET bromodomain inhibition as a therapeutic strategy to target c-Myc.
Cell;
146(6): 904-17, 2011 Sep 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-21889194
2.
Compartment-Specific Bioluminescence Imaging platform for the high-throughput evaluation of antitumor immune function.
Blood;
119(15): e131-8, 2012 Apr 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-22289890
3.
Lenalidomide targets clonogenic side population in multiple myeloma: pathophysiologic and clinical implications.
Blood;
117(17): 4409-19, 2011 Apr 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-21321360
4.
Small molecule branched-chain ketoacid dehydrogenase kinase (BDK) inhibitors with opposing effects on BDK protein levels.
Nat Commun;
14(1): 4812, 2023 08 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37558654
5.
Methyljasmonate displays in vitro and in vivo activity against multiple myeloma cells.
Br J Haematol;
159(3): 340-51, 2012 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-22970818
6.
Adenosine A2A receptor agonists and PDE inhibitors: a synergistic multitarget mechanism discovered through systematic combination screening in B-cell malignancies.
Blood;
116(4): 593-602, 2010 Jul 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-20382846
7.
Inhibition of tumor cells interacting with stromal cells by xanthones isolated from a Costa Rican Penicillium sp.
J Nat Prod;
75(4): 793-7, 2012 Apr 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-22458669
8.
AMPK activation is sufficient to increase skeletal muscle glucose uptake and glycogen synthesis but is not required for contraction-mediated increases in glucose metabolism.
Heliyon;
8(10): e11091, 2022 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-36303906
9.
Molecular and cellular effects of multi-targeted cyclin-dependent kinase inhibition in myeloma: biological and clinical implications.
Br J Haematol;
152(4): 420-32, 2011 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-21223249
10.
Anti-tumor activity and signaling events triggered by the isothiocyanates, sulforaphane and phenethyl isothiocyanate, in multiple myeloma.
Haematologica;
96(8): 1170-9, 2011 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-21712538
11.
In vitro anti-myeloma activity of the Aurora kinase inhibitor VE-465.
Br J Haematol;
147(5): 672-6, 2009 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-19751238
12.
Author Correction: Tumor cell-specific bioluminescence platform to identify stroma-induced changes to anticancer drug activity.
Nat Med;
30(4): 1214, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38355975
13.
Acyl Glucuronide Metabolites of 6-Chloro-5-[4-(1-hydroxycyclobutyl)phenyl]-1 H-indole-3-carboxylic Acid (PF-06409577) and Related Indole-3-carboxylic Acid Derivatives are Direct Activators of Adenosine Monophosphate-Activated Protein Kinase (AMPK).
J Med Chem;
61(16): 7273-7288, 2018 08 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-30036059
14.
Activation of Liver AMPK with PF-06409577 Corrects NAFLD and Lowers Cholesterol in Rodent and Primate Preclinical Models.
EBioMedicine;
31: 122-132, 2018 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-29673898
15.
Bcl-2 overexpression in thyroid carcinoma cells increases sensitivity to Bcl-2 homology 3 domain inhibition.
J Clin Endocrinol Metab;
92(12): 4845-52, 2007 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-17848408
16.
Activation of Skeletal Muscle AMPK Promotes Glucose Disposal and Glucose Lowering in Non-human Primates and Mice.
Cell Metab;
25(5): 1147-1159.e10, 2017 May 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-28467931
17.
The interaction of bortezomib with multidrug transporters: implications for therapeutic applications in advanced multiple myeloma and other neoplasias.
Cancer Chemother Pharmacol;
71(5): 1357-68, 2013 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-23589314
18.
Molecular and cellular effects of NEDD8-activating enzyme inhibition in myeloma.
Mol Cancer Ther;
11(4): 942-51, 2012 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-22246439
19.
Microenvironmental influence on pre-clinical activity of polo-like kinase inhibition in multiple myeloma: implications for clinical translation.
PLoS One;
6(7): e20226, 2011.
Artículo
en Inglés
| MEDLINE | ID: mdl-21750699
20.
Tumor cell-specific bioluminescence platform to identify stroma-induced changes to anticancer drug activity.
Nat Med;
16(4): 483-9, 2010 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-20228816